© 2020 MJH Life Sciences and HCPLive. All rights reserved.
© 2020 MJH Life Sciences™ and HCPLive. All rights reserved.
November 23, 2020
The lipid profile changes were not significant after 6 months, while the changes in the lipid profile are due to other factors and not the drugs.
November 19, 2020
The first-line atypical antipsychotic was linked to better outcomes in patients than comparators aripiprazole and olanzapine.
November 17, 2020
The agency did not find any efficacy or safety issues regarding the potential treatment for adults with schizophrenia or bipolar I disorder.
October 09, 2020
The schizophrenia drug currently has a PDUFA date set for November 15.
August 26, 2020
Tardive dyskinesia at treatment onset was the strongest predictor of schizophrenia relapse.
Telemedicine could be something that is still used, even after the COVID-19 pandemic is over.
August 25, 2020
An expert discusses ALKS 3831, a potential new treatment that demonstrated reduced weight gain in patients with schizophrenia compared to olanzapine.
August 23, 2020
The potential new treatment has demonstrated reduced weight gain in patients with schizophrenia compared to olanzapine.
August 19, 2020
Genetic and environmental liability were linked to poorer mental health in a cohort of more than 6000 individuals based in the Netherlands.
July 18, 2020
The number needed to treat to prevent at least 1 additional hospitalization was 7 individuals treated with aripiprazole once monthly compared with clinician’s choice.